Difference between revisions of "Vimentin (TG2)"
m |
m |
||
(One intermediate revision by one other user not shown) | |||
Line 1: | Line 1: | ||
{| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" | {| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" | ||
− | ! | + | ! {infobox header}| '''{{PAGENAME}}''' |
− | |||
− | |||
|- | |- | ||
| Substrate peptide name | | Substrate peptide name | ||
Line 54: | Line 52: | ||
| | | | ||
|- | |- | ||
− | | | + | | {infobox header} | |
|- | |- | ||
|} | |} | ||
[[Category:Tissue transglutaminase|*]] | [[Category:Tissue transglutaminase|*]] |
Latest revision as of 12:01, 10 March 2015
Vimentin (TG2) | |
---|---|
Substrate peptide name | Vimentin |
Synonyms | - |
Determination type | In vitro |
Source | Bos taurus |
Subcellular localization | Lens cytoskeleton |
Swissprot ID | P48616 |
Reactive glutamines | Q453, Q460 |
Reactive lysines | K97, K104, K294, K439 |
Substrate sequence | ETRDGQVINET
INETSQHHDDL INTEFKNTRTNEKVELQE EWYKSKFADLS VDTHSKRTFLI |
Structure | 1GK4 |
Surface accessibility | |
Disorder prediction | IUPred |
Reference | PMID:9516464 |
Notes | |